Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects [Yahoo! Finance]
Precigen, Inc. (PGEN)
Last precigen, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Outperform rating on Precigen Inc. (NASDAQ:PGEN) and hiked the price target to $9 from $8. Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects The price target hike underscores the research firm's confidence in the company's lead drug, PAPZIMEOS, as a frontline standard of care for recurrent respiratory papillomatosis. The drug received full FDA approval last year as the first immunotherapy for recurrent respiratory papillomatosis. Management has already indicated that they are on course to generate more than $18 million in PAPZIMEOS sales in the first quarter. Citizen's is confident sales will exceed guidance, given solid commercial metrics, including patient engagement and enrollment in hubs. Engaged patient profiles for papillomatosis are broad, including patients who have undergone many surgeries. The company remains well-positioned to capitalize on PAPZIMEOS edge as the first and only approved therapy for recurrent respiratory papilloma
Show less
Read more
Impact Snapshot
Event Time:
PGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGEN alerts
High impacting Precigen, Inc. news events
Weekly update
A roundup of the hottest topics
PGEN
News
- Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? [Yahoo! Finance]Yahoo! Finance
- Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point [Seeking Alpha]Seeking Alpha
- Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript [Seeking Alpha]Seeking Alpha
- Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat [Yahoo! Finance]Yahoo! Finance
- Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31PR Newswire
PGEN
Earnings
- 3/25/26 - Miss
PGEN
Sec Filings
- 3/31/26 - Form 4
- 3/31/26 - Form SCHEDULE
- 3/30/26 - Form 144
- PGEN's page on the SEC website